Core Viewpoint - The stock of Kefu Medical (301087) has shown a significant increase of 11.1% as of January 5, 2026, closing at 49.63 yuan, indicating positive market sentiment and trading activity [1]. Group 1: Stock Performance - On January 5, 2026, Kefu Medical's trading volume reached 98,100 lots, with a total transaction value of 477 million yuan [1]. - The stock experienced a turnover rate of 5.05%, reflecting active trading [1]. Group 2: Capital Flow - On January 5, 2026, the net outflow of main funds was 39.28 million yuan, accounting for 8.23% of the total transaction value, while retail investors saw a net inflow of 27.29 million yuan, representing 5.72% of the total [1]. - In the financing aspect, Kefu Medical had a net financing purchase of 20.55 million yuan on the same day, with total financing balance reaching 112 million yuan [2]. Group 3: Financial Performance - For the first three quarters of 2025, Kefu Medical reported a main revenue of 2.398 billion yuan, a year-on-year increase of 6.63%, and a net profit attributable to shareholders of 260 million yuan, up by 3.3% [3]. - In Q3 2025 alone, the company achieved a main revenue of 902 million yuan, marking a substantial year-on-year growth of 30.72%, with a net profit of approximately 92.83 million yuan, reflecting a 38.68% increase [3]. - The company's gross profit margin stands at 53.35%, with a debt ratio of 27.37% [3]. Group 4: Analyst Ratings - Over the past 90 days, eight institutions have provided ratings for Kefu Medical, with seven recommending a buy and one suggesting an increase in holdings [3]. - The average target price set by institutions in the last 90 days is 54.56 yuan [3].
可孚医疗（301087）1月5日主力资金净卖出3928.45万元